Optogenetic silencing by combining a rhodopsin cyclase with an engineered cGMP-gated potassium channel.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41313760.
- Also identified by DOI 10.1126/sciadv.adx1195 and PMC identifier 12662207.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Since the advent of optogenetics, great progress has been made in developing tools to modulate and detect cellular activity using light. We present a two-component optogenetic silencing tool, RoCK (rhodopsin cyclase/K<sup>+</sup> channel), which pairs the rhodopsin-guanylyl cyclase CaRhGC with customized SthK K<sup>+</sup> channels that are engineered to open selectively upon guanosine 3',5'-monophosphate (cGMP) binding. By enhancing the cGMP sensitivity and open probability of SthK mutants, we obtained four channel variants suited for different levels of cGMP concentration. CaRhGC's membrane-bound nature enables localized cGMP production, and the lack of dark activity reduces the risk for off-target effects. Optimized RoCK effectively modulated cellular activity in mouse hippocampal neurons, in acute hippocampal slices, and in rabbit cardiomyocytes. In zebrafish, RoCK silenced motor neurons in vivo, suppressing the characteristic coiling behavior of embryos, thus highlighting its potential for behavioral studies. In summary, RoCK expands our optogenetic toolkit threefold for fast cGMP production, fast cGMP sensing, and K<sup>+</sup>-based cell silencing.
Medical subject headings
- Cyclic GMP
- Optogenetics
- Potassium Channels
- Rhodopsin